Effect of Nano-crystalline Hydroxyapatite (SybografTM) Vs Beta Tri-Calcium Phosphate (Sybograf-TTM) in the Treatment of Intrabony Defects in Chronic Periodontitis Patients.
- Conditions
- Health Condition 1: null- Chronic Periodontitis patients with interproximalbone defects of 5 mm or more.
- Registration Number
- CTRI/2018/01/011375
- Lead Sponsor
- Abhishek singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Age group between 20-60years
2. Diagnosis with chronic periodontitis
3. Patients in good systemic health with no contraindication to periodontal surgery
4. Patients having infrabony defects with pocket depths of 5mm or
more and with radiographic evidence of vertical or angular bone loss
in the affected sites.
5. Involved teeth to be vital and asymptomatic
6. Systemically healthy individuals with no underlying medical conditions.
1. One â?? wall osseous defects.
2. Patients suffering from any systemic diseases or with
compromised immune system.
3. Patients who had received any type of periodontal therapy for the
past 6 months
4. Patients taking any immuno-suppressive drugs like corticosteroids
5. Patients with a known history of allergy to doxycycline or
Chlorhexidine or any other medicine be used in the study.
6. Patients showing unacceptable oral hygiene compliance during /
after the phase I therapy.
7. Patients taking any drug known to cause
gingival enlargement.
8. Pregnant and/or lactating mothers.
9. Patients who were smokers or had tobacco in any other form.
10. Endodontically treated teeth.
11. Patient on anticoagulant therapy
12. Patient with bleeding disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Plaque Index (P.I.) <br/ ><br>(Turskey-Gilmore-Glickman <br/ ><br>Modification Of Quigley Hein). <br/ ><br>2. Gingival Index (G.I.) (Loe & Silness, 1963). <br/ ><br>3. Probing Pocket Depth (PPD). <br/ ><br>4. Clinical Attachment Level (CAL).Timepoint: The clinical parameters are recorded at baseline, 1 month, 3 months, and 6 months after surgery.
- Secondary Outcome Measures
Name Time Method Radiographic bone fill will be evaluated using <br/ ><br>intraoral periapical radiographs of the surgical <br/ ><br>site.Timepoint: Radiographs will be taken at baseline, <br/ ><br>immediately after surgery and at sixth month after <br/ ><br>surgery.